Astellas Establishes New Subsidiary 'Astellas Pharma Chemicals Co., Ltd.'.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Apr 3, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Astellas Pharma Astellas Pharma Inc. (アステラス製薬株式会社 Inc.(TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4503) announced that Astellas today established a new active pharmaceutical ingredient (API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol. ) manufacturing subsidiary "Astellas Pharma Chemicals Co., Ltd." through a company split. Astellas separated its Takahagi Plant, the manufacturing and analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. function for APIs for investigational use at the Process Chemistry Labs. and the site management function of the Bulk Technology Administration and transferd to Astellas Pharma Chemicals Co., Ltd. The new subsidiary has through function for the production of APIs for investigational use and finished products and will contribute to the timely and accurate supply of APIs for investigational use, early establishment of new product production, the stable supply of products and the improvement of API manufacturing technology of the Astellas group. The details of the new subsidiary are as follows: Company name: Astellas Pharma Chemicals Co., Ltd. Location: 160-2, Akahama, Takahagi city, Ibaraki Prefecture Representative: Motoyoshi Katano, President Capital: 100 million yen Number of employees: about 100 Establishment: April 3, 2006 Business: Production and marketing of drugs and other products About Astellas Pharma Inc. Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. In April 2005, the company was formed through the merger of Fujisawa Fujisawa (f  jē`säwä), city (1990 pop. 350,330), Kanagawa prefecture, central Honshu, Japan, on Sagami Bay. Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co.,
Ltd. The organization is committed to becoming a global mega
pharmaceutical company by combining outstanding R&D and marketing
capabilities and continuing to grow in the world pharmaceutical market.
For more information on Astellas Pharma Inc., please visit the
company's website at www.astellas.com.Source: Astellas Pharma Inc. Contact: Astellas Pharma Inc. Corporate Communications Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com Copyright [c] 2006 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion